<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03752866</url>
  </required_header>
  <id_info>
    <org_study_id>SJM-CIP-CL1003491</org_study_id>
    <nct_id>NCT03752866</nct_id>
  </id_info>
  <brief_title>The CONFIDENCE Registry</brief_title>
  <official_title>CONtrolled Delivery For ImproveD outcomEs With cliNiCal Evidence</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Abbott Medical Devices</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Abbott Medical Devices</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this clinical investigation is to characterize the procedural safety and
      device performance of transfemoral implantation of the Portico™ Transcatheter Aortic Heart
      Valve in patients with symptomatic degenerative aortic stenosis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The CONFIDENCE registry study will be conducting as a prospective, non-randomized,
      observational, single-arm, multi-center study.

      Approximately 1000 subjects with severe symptomatic (NYHA class ≥ II) aortic stenosis (AS),
      will undergo Portico™ Transcatheter Aortic Heart Valve implantation.

      The subject data will be collected at baseline, index procedure, pre- discharge, 30 days and
      12 months from the index procedure.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 25, 2018</start_date>
  <completion_date type="Anticipated">December 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>This registry will include market released Portico™ valves (23mm, 25mm, 27mm and 29mm), delivery systems and loading systems. The registry will also allow future iterations of the Portico valve and delivery system along with expanded indications to be included as they receive approval for commercial use in the country where the subject is enrolled.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Cardiovascular Mortality</measure>
    <time_frame>At 30 days post index procedure</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Myocardial Infarction (MI)</measure>
    <time_frame>At 30 days post index procedure</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Stroke (including disabling and non-disabling)</measure>
    <time_frame>At 30 days post index procedure</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Bleeding (life-threatening, major, minor)</measure>
    <time_frame>At 30 days post index procedure</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Acute kidney injury</measure>
    <time_frame>At 30 days post index procedure</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Vascular access site and access-related complications (major and minor)</measure>
    <time_frame>At 30 days post index procedure</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Annular rupture</measure>
    <time_frame>At 30 days post index procedure</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Conversion to open surgery</measure>
    <time_frame>At 30 days post index procedure</time_frame>
    <description>VARC-2 definition of conversion to open surgery: Conversion to open sternotomy during the TAVI procedure secondary to any procedure-related complications</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Coronary obstruction</measure>
    <time_frame>At 30 days post index procedure</time_frame>
    <description>As per VARC-2 criteria: Angiographic or echocardiographic evidence of a new, partial or complete, obstruction of a coronary ostium, either by the valve prosthesis itself, the native leaflets, calcifications, or dissection, occurring during or after the TAVI procedure</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Valve embolization</measure>
    <time_frame>At 30 days post index procedure</time_frame>
    <description>As per VARC-2 criteria: The valve prosthesis moves during or after deployment such that it loses contact with the aortic annulus</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Transcatheter valve-in-valve deployment</measure>
    <time_frame>At 30 days post index procedure</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Permanent pacemaker insertion</measure>
    <time_frame>At 30 days post index procedure</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Delivery profile characteristics</measure>
    <time_frame>At 30 days post index procedure</time_frame>
    <description>Delivery profile characteristics assess access vessel diameter, sheath utilization and sheath size</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Implant success</measure>
    <time_frame>At 30 days post index procedure</time_frame>
    <description>Implant success defined as:
Absence of procedural mortality
Correct positioning of a single Portico prosthetic heart valve into the proper anatomical location</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Echocardiographic assessment of hemodynamic valve performance</measure>
    <time_frame>At 30 days post index procedure</time_frame>
    <description>Echocardiographic assessment of hemodynamic valve performance include:
Mean gradient
Effective orifice area
Paravalvular leak (PVL)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Clinical improvement from baseline</measure>
    <time_frame>At 30 days post index procedure</time_frame>
    <description>Clinical improvement from baseline assessed by:
New York Heart Association (NYHA) functional class change from Baseline to 30 days
Quality of Life (QoL) questionnaire (EQ5D-3L) changes from baseline to 30 days</description>
  </primary_outcome>
  <primary_outcome>
    <measure>All-cause mortality</measure>
    <time_frame>At 30 days post index procedure</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>All-cause mortality</measure>
    <time_frame>At 12 months post index procedure</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Symptomatic Degenerative Aortic Stenosis</condition>
  <condition>Severe Aortic Stenosis</condition>
  <arm_group>
    <arm_group_label>Portico™ Valve, Delivery System(s) and Loading Systems(s)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Portico™ Valve, Delivery System(s) and Loading Systems(s)</intervention_name>
    <description>Subjects will undergo implantation of a commercially available Portico transcatheter aortic heart valve</description>
    <arm_group_label>Portico™ Valve, Delivery System(s) and Loading Systems(s)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subjects who are &gt;18 years of age or legal age in host country and have been
             identified as a candidate for a Portico™ valve implant

          -  Subjects who have been informed of the nature of the study, agree to its provisions
             and have provided written informed consent as approved by the Ethics Committee (EC) of
             the respective clinical center

        Exclusion Criteria:

        Candidates will be excluded if any of the following conditions are present:

          1. Have sepsis, including active endocarditis

          2. Have any evidence of left ventricular or atrial thrombus

          3. Have vascular conditions (i.e. caliber, stenosis, tortuosity, or severe calcification)
             that make insertion and endovascular access to the aortic valve improbable

          4. Have a non-calcified aortic annulus

          5. Have congenital bicuspid or unicuspid leaflet configuration

          6. Are unable to tolerate antiplatelet/anticoagulant therapy

          7. Are pregnant at the time of signing informed consent

          8. Are currently participating in a drug or device study that may impact the registry
             (unless prior sponsor approval for co-enrollment is granted)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Helge Möllmann</last_name>
    <role>Principal Investigator</role>
    <affiliation>St. Johannes Hospital, Dortmund, Germany</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mira Tissari</last_name>
    <phone>+32470470942</phone>
    <email>mira.tissari@abbott.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Mariella Van Ransbeeck</last_name>
    <phone>+32(0)27746829</phone>
    <email>mariella.vanransbeeck@abbott.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Heart Care Partners- Wesley Hospital</name>
      <address>
        <city>Woolloongabba</city>
        <state>Queensland</state>
        <zip>4102</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anthony Camuglia, M.D.</last_name>
    </contact>
    <investigator>
      <last_name>Anthony Camuglia, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>AZ Middelheim</name>
      <address>
        <city>Antwerpen</city>
        <zip>2020</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Stefan Verheye, M.D.</last_name>
    </contact>
    <investigator>
      <last_name>Stefan Verheye, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospital Olomouc</name>
      <address>
        <city>Olomouc</city>
        <zip>77900</zip>
        <country>Czechia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Martin Sluka, M.D.</last_name>
    </contact>
    <investigator>
      <last_name>Martin Sluka, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kliniken der Friedrich-Alexander-Universitat</name>
      <address>
        <city>Erlangen</city>
        <state>Bavaria</state>
        <zip>91054</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Martin Arnold, Dr. med.</last_name>
    </contact>
    <investigator>
      <last_name>Martin Arnold, Dr. med.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kerckhoff-Klinik gGmbH</name>
      <address>
        <city>Bad Nauheim</city>
        <zip>61231</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Won-Keun Kim, Dr. med.</last_name>
    </contact>
    <investigator>
      <last_name>Won-Keun Kim, Dr. med.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Charite Campus Virchow Klinikum</name>
      <address>
        <city>Berlin-Mitte</city>
        <zip>13353</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Florian Krackhardt, Dr. med.</last_name>
    </contact>
    <investigator>
      <last_name>Florian Krackhardt, Dr. med.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitätsmedizin Berlin - Charité Campus Mitte (CCM)</name>
      <address>
        <city>Berlin</city>
        <zip>10117</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Henryk Dreger, Dr. med.</last_name>
    </contact>
    <investigator>
      <last_name>Henryk Dreger, Dr. med.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitätsmedizin Berlin - Campus Benjamin Franklin (CBF)</name>
      <address>
        <city>Berlin</city>
        <zip>12203</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexander Lauten, PD Dr. med.</last_name>
    </contact>
    <investigator>
      <last_name>Alexander Lauten, PD Dr. med.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St.-Johannes-Hospital</name>
      <address>
        <city>Dortmund</city>
        <zip>44137</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Helge Moellmann</last_name>
    </contact>
    <investigator>
      <last_name>Helge Moellmann, Prof. Dr. med.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Herzzentrum Dresden GmbH Universitätsklinik</name>
      <address>
        <city>Dresden</city>
        <zip>01307</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Axel Linke, Prof. Dr. med.</last_name>
    </contact>
    <investigator>
      <last_name>Axel Linke, Prof. Dr. med.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Klinikum der Johann Wolfgang Goethe-Universität Frankfurt</name>
      <address>
        <city>Frankfurt</city>
        <zip>60590</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mariuca Vasa-Nicotera, Dr. med.</last_name>
    </contact>
    <investigator>
      <last_name>Mariuca Vasa-Nicotera, Dr. med.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>UKE Hamburg (Universitatsklinik Eppendorf)</name>
      <address>
        <city>Hamburg</city>
        <zip>20246</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lenard Conradi, Dr. med.</last_name>
    </contact>
    <investigator>
      <last_name>Lenard Conradi, Dr. med.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Städtisches Klinikum Karlsruhe gGmbH Medizinischen Klinik IV</name>
      <address>
        <city>Karlsruhe</city>
        <zip>76133</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gerhard Schymik, Dr.med</last_name>
    </contact>
    <investigator>
      <last_name>Gerhard Schymik, Dr.med</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitätsmedizin der Johannes Gutenberg-Universität Mainz</name>
      <address>
        <city>Mainz</city>
        <zip>55131</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Policlinico di Monza</name>
      <address>
        <city>Monza</city>
        <state>Lombardy</state>
        <zip>20900</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Giovanni Sorropago, M.D.</last_name>
    </contact>
    <investigator>
      <last_name>Giovanni Sorropago, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ospedale San Raffaele</name>
      <address>
        <city>Milano</city>
        <zip>20132</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Matteo Montorfano, M.D.</last_name>
    </contact>
    <investigator>
      <last_name>Matteo Montorfano, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Policlinico San Donato</name>
      <address>
        <city>San Donato Milanese</city>
        <zip>20097</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Francesco Bedogni, M.D.</last_name>
    </contact>
    <investigator>
      <last_name>Francesco Bedogni, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ospedale San Bortolo</name>
      <address>
        <city>Vicenza</city>
        <zip>36100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Giovanna Erente, M.D.</last_name>
    </contact>
    <investigator>
      <last_name>Giovanna Erente, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Samodzielny Publiczny Centralny Szpital Kliniczny</name>
      <address>
        <city>Warsaw</city>
        <state>Mazovia</state>
        <zip>02-097</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Janusz Kochman, M.D.</last_name>
    </contact>
    <investigator>
      <last_name>Janusz Kochman, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital de la Santa Creu I Sant Pau</name>
      <address>
        <city>Barcelona</city>
        <state>Catalonia</state>
        <zip>08025</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dabit Arzamendi, M.D.</last_name>
    </contact>
    <investigator>
      <last_name>Dabit Arzamendi, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital General Juan Ramon Jimenez</name>
      <address>
        <city>Huelva</city>
        <zip>21005</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>José Diaz, M.D.</last_name>
    </contact>
    <investigator>
      <last_name>José Diaz, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Clinico San Carlos</name>
      <address>
        <city>Madrid</city>
        <zip>28040</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Luis Nombela, M.D.</last_name>
    </contact>
    <investigator>
      <last_name>Luis Nombela, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Puerta de Hierro</name>
      <address>
        <city>Madrid</city>
        <zip>28222</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Javier Goicolea, M.D.</last_name>
    </contact>
    <investigator>
      <last_name>Javier Goicolea, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kantonsspital Aarau</name>
      <address>
        <city>Aarau</city>
        <zip>5001</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Royal Victoria Hospital</name>
      <address>
        <city>Belfast</city>
        <state>Ireland</state>
        <zip>BT12 6BA</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ganesh Manoharan, M.D.</last_name>
    </contact>
    <investigator>
      <last_name>Ganesh Manoharan, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>James Cook University Hoospital</name>
      <address>
        <city>Middlesbrough</city>
        <state>North East England</state>
        <zip>TS4 3BW</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dougie Muir, M.D.</last_name>
    </contact>
    <investigator>
      <last_name>Dougie Muir, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Morriston Hospital - ABM University Health Board</name>
      <address>
        <city>Morriston</city>
        <state>Swansea</state>
        <zip>SA6 6NL</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dave Smith, M.D.</last_name>
    </contact>
    <investigator>
      <last_name>Dave Smith, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>King's College Hospital</name>
      <address>
        <city>London</city>
        <zip>SE5 9RS</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Philip MacCarthy, M.D.</last_name>
    </contact>
    <investigator>
      <last_name>Philip MacCarthy, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Australia</country>
    <country>Belgium</country>
    <country>Czechia</country>
    <country>Germany</country>
    <country>Italy</country>
    <country>Poland</country>
    <country>Spain</country>
    <country>Switzerland</country>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>November 15, 2018</study_first_submitted>
  <study_first_submitted_qc>November 23, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">November 26, 2018</study_first_posted>
  <last_update_submitted>July 3, 2020</last_update_submitted>
  <last_update_submitted_qc>July 3, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 7, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Portico™ valve</keyword>
  <keyword>Portico™ valve delivery system</keyword>
  <keyword>Portico™ valve loading system</keyword>
  <keyword>Transcatheter Aortic Valve Replacement</keyword>
  <keyword>Aortic Stenosis</keyword>
  <keyword>Heart Valve Prosthesis</keyword>
  <keyword>TAVR</keyword>
  <keyword>TAVR Registry</keyword>
  <keyword>Transcatheter Aortic Valve Implant</keyword>
  <keyword>TAVI</keyword>
  <keyword>TAVI Registry</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aortic Valve Stenosis</mesh_term>
    <mesh_term>Constriction, Pathologic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

